How DTx Will Set the Standard for Evidence in Digital Health: A Presentation from DTx West
Watch reply
DTx might be the future of mental health care. But only if companies prioritize high-quality research above quick turnaround.
Are digital therapeutics (DTx) the future of mental health care?
Originally presented at the DTx West 2021 Conference on February 25th 2021.

Join Big Health’s Dr. Jenna Carl, VP of Clinical Development and Medical Affairs as she moderates a panel discussion with Dr. Andrew Krystal of UCSF, Dr. Juliette McClendon from Boston University, Dr. Jordan Silberman from Anthem, and Brian Dolan from Exits and Outcomes, on the importance of clinical evidence to the future of digital therapeutics.
Don’t have time to watch the full video? We got your back. Check out our blog highlighting the key takeaways from the panel.
Watch more
View all

A Patient-First Perspective on Digital Therapeutics: A Presentation from DTx West
Two employees speak about the life-changing experience of using Sleepio and Daylight, digital therapeutics for poor sleep and worry and anxiety.
View webinar

Mental health equity: barriers and solutions
Dr. McClendon, an expert on how racism shapes mental health disparities, discusses how employers can address stigma, equitable access, and the social determinants of health.
View webinar